INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes.
David Dunger,
Sylvaine FA Bruggraber,
Adrian P Mander,
Loredana Marcovecchio,
Timothy Tree,
Piotr Jaroslaw Chmura,
Mikael Knip,
Anke M Schulte,
Chantal Mathieu,
INNODIA consortium
May 18, 2022
BACKGROUND: The INNODIA consortium has established a pan-European infrastructure using validated centres to prospectively evaluate clinical data from individuals with newly diagnosed type 1 diabetes combined with centralised...